22,135,656
Vote Records
28,570
Companies
12,092
Funds
3,981
Managers

Home › Companies › TG THERAPEUTICS INC. › 2024-2025

TG THERAPEUTICS INC. 2024-2025 Proxy Voting Records

Download data (CSV): ballot items · votes by manager · column guide.

Compiled from SEC Form N-PX filings and TG THERAPEUTICS INC.’s Form 8-K, filed June 13, 2025 (Item 5.07 on EDGAR). Page generated November 20, 2026.

  • 9Ballot items
  • 343Asset managers, any item
  • 3,068Fund votes
  • June 12, 2025Meeting date

Results at a glance

Meeting of June 12, 2025: 9 items on TG THERAPEUTICS INC.’s Form 8-K, filed June 13, 2025: 9 passed (calculated).

Dissent

Significant dissent: 4 directors (45.9%, 41.4%, 41.1%, 39.5% against); 1 say-on-pay vote (54.5% support).

Notable dissent: 2 directors (19.4%, 14.4% against).

Dissent tiers, on the company’s own Form 8-K tally (support = FOR ÷ (FOR + AGAINST), or FOR ÷ (FOR + WITHHELD) on a withhold ballot; abstentions and broker non-votes excluded): shareholder proposals with 15% support or more are notable, 25% significant, 40% high; director nominees with 10% or more against or withheld are notable, 20% significant; say-on-pay under 80% support is notable, under 70% significant; equity and compensation plans with 15% or more against are notable, 25% significant; any other item the board put forward with 15% or more against is notable. How this is decided

Proxy season: 2023-2024 2024-2025 2025-2026

Explore TG THERAPEUTICS INC. in the interactive database Compare manager voting policies

Official 2024-2025 meeting results reported by TG THERAPEUTICS INC.

These tallies are TG THERAPEUTICS INC.’s own, as disclosed to the U.S. Securities and Exchange Commission on Form 8-K, filed June 13, 2025 (Item 5.07, “Submission of Matters to a Vote of Security Holders”). They cover every share voted at the meeting, not just the funds that file Form N-PX.

TG THERAPEUTICS INC. — official shareholder meeting results, meeting held June 12, 2025
Ballot itemForAgainst AbstainWithheldBroker non-votesSupport (of votes cast)Reported outcomeVoting standard
Elect Director: Michael S. Weiss 75,488,727---- 12,748,31830,193,346 86%Passed (calculated)—
Elect Director: Laurence N. Charney 71,087,304---- 17,149,74130,193,346 81%Passed (calculated)—
Elect Director: Yann Echelard 51,734,184---- 36,502,86130,193,346 59%Passed (calculated)—
Elect Director: Kenneth Hoberman 53,398,586---- 34,838,45930,193,346 61%Passed (calculated)—
Elect Director: Daniel Hume 51,965,829---- 36,271,21630,193,346 59%Passed (calculated)—
Elect Director: Sagar Lonial, MD 47,757,163---- 40,479,88230,193,346 54.1%Passed (calculated)—
2. The ratification of KPMG LLP as the Company's independent registered public accounting firm for the fiscal year ending December 31, 2025 117,836,086442,199152,106 ---- 99.6%Passed (calculated)—
3. Advisory vote to approve the compensation of the Company's named executive officers 47,864,73739,988,402383,906 --30,193,346 54.5%Passed (calculated)—
4. The vote to approve the amendment to the Company's 2022 Incentive Plan to increase the number of authorized shares of Common Stock authorized for issuance under the 2022 Incentive Plan from 17,000,000 to 22,000,000 82,034,5925,788,439414,014 --30,193,346 93%Passed (calculated)—

Source: TG THERAPEUTICS INC., Form 8-K, filed with the SEC on June 13, 2025 — read the filing on EDGAR.

How asset managers voted at the TG THERAPEUTICS INC. 2024-2025 meeting

343 asset managers disclosed a vote on at least one TG THERAPEUTICS INC. item in their SEC Form N-PX filings. Each item below shows how many of them voted on it, and how. Share totals are the shares those managers' funds voted, summed across every fund they report.

Elect Director: Laurence N. Charney

Calculated outcomeDIRECTOR ELECTIONSPassed (calculated)

Combines 6 wordings of this item as funds reported it.

81% Majority: yes · of votes cast

FOR 81%WITHHELD
FOR: 71,087,304WITHHELD: 17,149,741

Prior year: 75.9% for (June 14, 2024 meeting) ▲ 4.7 pts

Details: description as filed, official tally, votes by 86 asset managers

Description as filed by funds: Election of Directors: Laurence Charney

TG THERAPEUTICS INC.’s own tally for this item (“Elect Director: Laurence N. Charney”): 71,087,304 for, 17,149,741 withheld, per its Form 8-K filed June 13, 2025 (Item 5.07). FOR was more than half of the votes cast. Whether the item passed is for the filing to say; its statement has not been read for this item.

Outcome: Passed (calculated) — The company’s filing reports the vote counts but does not state the outcome; we calculated it from the counts: votes for exceeded votes against.
Support: 81% of votes cast — FOR ÷ (FOR + WITHHELD); abstentions and broker non-votes are excluded.

The 86 asset managers below reported 34,782,826 for, 5,438,619 withheld, 549,076 abstained.

FOR
FOR: 34,782,826ABSTAIN: 549,076WITHHOLD: 5,438,619
Largest asset managers voting on “Election of Directors: Laurence Charney” at TG THERAPEUTICS INC., 2024-2025
Asset managerForAgainst AbstainWithheldVote
Vanguard16,230,9880 4221,525For
BlackRock7,948,9740 00For
Fidelity3,879,6920 015,500For
State Street2,208,6310 02,694For
Legg Mason1,409,1000 014,051For
Charles Schwab00 01,151,892Withhold
Manager Directed Portfolios850,9820 00For
MUTUAL FUND SERIES TRUST00 0718,814Withhold
Invesco444,2330 00For
Lord Abbett00 0428,862Withhold
Equitable262,6700 0159,810Mixed
Jackson National00 338,3650Abstain
Columbia Threadneedle285,8260 00For
TIAA267,8390 00For
Goldman Sachs00 0258,676Withhold
T. Rowe Price00 0255,946Withhold
QUANTITATIVE MASTER SERIES LLC237,9340 00For
Voya229,7670 00For
First Trust00 0196,832Withhold
Northwestern Mutual00 0174,181Withhold
DRIEHAUS MUTUAL FUNDS00 0162,578Withhold
Lincoln Financial102,8000 056,274Mixed
Hartford00 0150,709Withhold
Principal Exchange-Traded Funds00 0132,282Withhold
Principal00 0129,934Withhold

Showing the 25 largest of 86 asset managers. All 86 are in the interactive database (link above).

Elect Director: Daniel Hume

Calculated outcomeDIRECTOR ELECTIONSPassed (calculated)

Combines 6 wordings of this item as funds reported it.

59% Majority: yes · of votes cast

FOR 59%WITHHELD
FOR: 51,965,829WITHHELD: 36,271,216

Prior year: 46.0% for (June 14, 2024 meeting) ▲ 12.9 pts

Details: description as filed, official tally, votes by 85 asset managers

Description as filed by funds: Election of Directors: Daniel Hume

TG THERAPEUTICS INC.’s own tally for this item (“Elect Director: Daniel Hume”): 51,965,829 for, 36,271,216 withheld, per its Form 8-K filed June 13, 2025 (Item 5.07). FOR was more than half of the votes cast. Whether the item passed is for the filing to say; its statement has not been read for this item.

Outcome: Passed (calculated) — The company’s filing reports the vote counts but does not state the outcome; we calculated it from the counts: votes for exceeded votes against.
Support: 59% of votes cast — FOR ÷ (FOR + WITHHELD); abstentions and broker non-votes are excluded.

The 85 asset managers below reported 19,883,996 for, 11,953,811 withheld, 8,848,714 abstained.

FORABSTAINWITHHOLD
FOR: 19,883,996ABSTAIN: 8,848,714WITHHOLD: 11,953,811
Largest asset managers voting on “Election of Directors: Daniel Hume” at TG THERAPEUTICS INC., 2024-2025
Asset managerForAgainst AbstainWithheldVote
Vanguard15,341,4730 58911,025Mixed
BlackRock00 7,948,9740Abstain
Fidelity2,513,5020 01,381,690Mixed
State Street5,3380 02,205,987Withhold
Legg Mason00 01,423,151Withhold
Charles Schwab00 01,151,892Withhold
Manager Directed Portfolios850,9820 00For
MUTUAL FUND SERIES TRUST00 0718,814Withhold
Invesco444,2330 00For
Lord Abbett00 0428,862Withhold
Equitable00 0422,480Withhold
Jackson National00 338,3650Abstain
Columbia Threadneedle285,8260 00For
TIAA00 0267,839Withhold
Goldman Sachs00 0258,676Withhold
T. Rowe Price00 0255,946Withhold
QUANTITATIVE MASTER SERIES LLC00 237,9340Abstain
Voya229,7670 00For
First Trust00 0196,832Withhold
Northwestern Mutual46,1000 0128,081Mixed
DRIEHAUS MUTUAL FUNDS00 0162,578Withhold
Lincoln Financial00 0159,074Withhold
Hartford00 0150,709Withhold
Principal Exchange-Traded Funds00 0132,282Withhold
Principal00 0129,934Withhold

Showing the 25 largest of 85 asset managers. All 85 are in the interactive database (link above).

Elect Director: Kenneth Hoberman

Calculated outcomeDIRECTOR ELECTIONSPassed (calculated)

Combines 6 wordings of this item as funds reported it.

61% Majority: yes · of votes cast

FOR 61%WITHHELD
FOR: 53,398,586WITHHELD: 34,838,459

Prior year: 68.4% for (June 14, 2024 meeting) ▼ 7.9 pts

Details: description as filed, official tally, votes by 85 asset managers

Description as filed by funds: Election of Directors: Kenneth Hoberman

TG THERAPEUTICS INC.’s own tally for this item (“Elect Director: Kenneth Hoberman”): 53,398,586 for, 34,838,459 withheld, per its Form 8-K filed June 13, 2025 (Item 5.07). FOR was more than half of the votes cast. Whether the item passed is for the filing to say; its statement has not been read for this item.

Outcome: Passed (calculated) — The company’s filing reports the vote counts but does not state the outcome; we calculated it from the counts: votes for exceeded votes against.
Support: 61% of votes cast — FOR ÷ (FOR + WITHHELD); abstentions and broker non-votes are excluded.

The 85 asset managers below reported 22,508,158 for, 9,329,651 withheld, 8,848,712 abstained.

FORABSTAINWITHHOLD
FOR: 22,508,158ABSTAIN: 8,848,712WITHHOLD: 9,329,651
Largest asset managers voting on “Election of Directors: Kenneth Hoberman” at TG THERAPEUTICS INC., 2024-2025
Asset managerForAgainst AbstainWithheldVote
Vanguard16,230,9740 5621,525For
BlackRock00 7,948,9740Abstain
Fidelity1,243,7150 02,651,477Mixed
State Street2,208,6310 02,694For
Legg Mason1,409,1000 014,051For
Charles Schwab00 01,151,892Withhold
Manager Directed Portfolios850,9820 00For
MUTUAL FUND SERIES TRUST00 0718,814Withhold
Invesco00 0444,233Withhold
Lord Abbett00 0428,862Withhold
Equitable40,7000 0381,780Mixed
Jackson National00 338,3650Abstain
Columbia Threadneedle00 0285,826Withhold
TIAA267,8390 00For
Goldman Sachs00 0258,676Withhold
T. Rowe Price00 0255,946Withhold
QUANTITATIVE MASTER SERIES LLC00 237,9340Abstain
Voya00 0229,767Withhold
First Trust00 0196,832Withhold
Northwestern Mutual00 0174,181Withhold
DRIEHAUS MUTUAL FUNDS00 0162,578Withhold
Lincoln Financial102,8000 056,274Mixed
Hartford00 0150,709Withhold
Principal Exchange-Traded Funds00 0132,282Withhold
Principal00 0129,934Withhold

Showing the 25 largest of 85 asset managers. All 85 are in the interactive database (link above).

Elect Director: Michael S. Weiss

Calculated outcomeDIRECTOR ELECTIONSPassed (calculated)

Combines 6 wordings of this item as funds reported it.

86% Majority: yes · of votes cast

FOR 86%WITHHELD
FOR: 75,488,727WITHHELD: 12,748,318

Prior year: 75.2% for (June 14, 2024 meeting) ▲ 10.3 pts

Details: description as filed, official tally, votes by 85 asset managers

Description as filed by funds: Election of Directors: Michael S. Weiss

TG THERAPEUTICS INC.’s own tally for this item (“Elect Director: Michael S. Weiss”): 75,488,727 for, 12,748,318 withheld, per its Form 8-K filed June 13, 2025 (Item 5.07). FOR was more than half of the votes cast. Whether the item passed is for the filing to say; its statement has not been read for this item.

Outcome: Passed (calculated) — The company’s filing reports the vote counts but does not state the outcome; we calculated it from the counts: votes for exceeded votes against.
Support: 86% of votes cast — FOR ÷ (FOR + WITHHELD); abstentions and broker non-votes are excluded.

The 85 asset managers below reported 36,317,507 for, 3,873,970 withheld, 495,044 abstained.

FOR
FOR: 36,317,507ABSTAIN: 495,044WITHHOLD: 3,873,970
Largest asset managers voting on “Election of Directors: Michael S. Weiss” at TG THERAPEUTICS INC., 2024-2025
Asset managerForAgainst AbstainWithheldVote
Vanguard16,238,5240 3114,000For
BlackRock7,948,9740 00For
Fidelity3,879,6920 015,500For
State Street2,208,6310 02,694For
Legg Mason1,409,1000 014,051For
Charles Schwab1,151,8920 00For
Manager Directed Portfolios850,9820 00For
MUTUAL FUND SERIES TRUST00 0718,814Withhold
Invesco444,2330 00For
Lord Abbett00 0428,862Withhold
Equitable262,6700 0159,810Mixed
Jackson National00 338,3650Abstain
Columbia Threadneedle285,8260 00For
TIAA00 0267,839Withhold
Goldman Sachs258,6760 00For
T. Rowe Price00 0255,946Withhold
QUANTITATIVE MASTER SERIES LLC237,9340 00For
Voya229,7670 00For
First Trust00 0196,832Withhold
Northwestern Mutual46,1000 0128,081Mixed
DRIEHAUS MUTUAL FUNDS00 0162,578Withhold
Lincoln Financial102,8000 056,274Mixed
Hartford00 0150,709Withhold
Principal Exchange-Traded Funds00 0132,282Withhold
Principal00 0129,934Withhold

Showing the 25 largest of 85 asset managers. All 85 are in the interactive database (link above).

Elect Director: Sagar Lonial, MD

Calculated outcomeDIRECTOR ELECTIONSPassed (calculated)

Combines 6 wordings of this item as funds reported it.

54.1% Majority: yes · of votes cast

FOR 54.1%WITHHELD
FOR: 47,757,163WITHHELD: 40,479,882

Prior year: 43.8% for (June 14, 2024 meeting) ▲ 10.4 pts

Details: description as filed, official tally, votes by 85 asset managers

Description as filed by funds: Election of Directors: Sagar Lonial, MD

TG THERAPEUTICS INC.’s own tally for this item (“Elect Director: Sagar Lonial, MD”): 47,757,163 for, 40,479,882 withheld, per its Form 8-K filed June 13, 2025 (Item 5.07). FOR was more than half of the votes cast. Whether the item passed is for the filing to say; its statement has not been read for this item.

Outcome: Passed (calculated) — The company’s filing reports the vote counts but does not state the outcome; we calculated it from the counts: votes for exceeded votes against.
Support: 54.1% of votes cast — FOR ÷ (FOR + WITHHELD); abstentions and broker non-votes are excluded.

The 85 asset managers below reported 16,904,224 for, 14,982,326 withheld, 8,799,970 abstained.

FORABSTAINWITHHOLD
FOR: 16,904,224ABSTAIN: 8,799,970WITHHOLD: 14,982,326
Largest asset managers voting on “Election of Directors: Sagar Lonial, MD” at TG THERAPEUTICS INC., 2024-2025
Asset managerForAgainst AbstainWithheldVote
Vanguard15,341,4620 68911,025Mixed
BlackRock00 7,948,9740Abstain
Fidelity00 03,895,192Withhold
State Street5,3380 02,205,987Withhold
Legg Mason00 01,423,151Withhold
Charles Schwab00 01,151,892Withhold
Manager Directed Portfolios850,9820 00For
MUTUAL FUND SERIES TRUST00 0718,814Withhold
Invesco444,2330 00For
Lord Abbett00 0428,862Withhold
Equitable00 0422,480Withhold
Jackson National00 338,3650Abstain
Columbia Threadneedle00 0285,826Withhold
TIAA00 0267,839Withhold
Goldman Sachs00 0258,676Withhold
T. Rowe Price00 0255,946Withhold
QUANTITATIVE MASTER SERIES LLC00 237,9340Abstain
Voya00 0229,767Withhold
First Trust00 0196,832Withhold
Northwestern Mutual46,1000 0128,081Mixed
DRIEHAUS MUTUAL FUNDS00 0162,578Withhold
Lincoln Financial00 0159,074Withhold
Hartford00 0150,709Withhold
Principal Exchange-Traded Funds00 0132,282Withhold
Principal00 0129,934Withhold

Showing the 25 largest of 85 asset managers. All 85 are in the interactive database (link above).

Elect Director: Yann Echelard

Calculated outcomeDIRECTOR ELECTIONSPassed (calculated)

Combines 6 wordings of this item as funds reported it.

59% Majority: yes · of votes cast

FOR 59%WITHHELD
FOR: 51,734,184WITHHELD: 36,502,861

Prior year: 46.0% for (June 14, 2024 meeting) ▲ 12.6 pts

Details: description as filed, official tally, votes by 85 asset managers

Description as filed by funds: Election of Directors: Yann Echelard

TG THERAPEUTICS INC.’s own tally for this item (“Elect Director: Yann Echelard”): 51,734,184 for, 36,502,861 withheld, per its Form 8-K filed June 13, 2025 (Item 5.07). FOR was more than half of the votes cast. Whether the item passed is for the filing to say; its statement has not been read for this item.

Outcome: Passed (calculated) — The company’s filing reports the vote counts but does not state the outcome; we calculated it from the counts: votes for exceeded votes against.
Support: 59% of votes cast — FOR ÷ (FOR + WITHHELD); abstentions and broker non-votes are excluded.

The 85 asset managers below reported 19,881,753 for, 11,956,053 withheld, 8,848,714 abstained.

FORABSTAINWITHHOLD
FOR: 19,881,753ABSTAIN: 8,848,714WITHHOLD: 11,956,053
Largest asset managers voting on “Election of Directors: Yann Echelard” at TG THERAPEUTICS INC., 2024-2025
Asset managerForAgainst AbstainWithheldVote
Vanguard15,341,4720 58911,025Mixed
BlackRock00 7,948,9740Abstain
Fidelity2,513,5020 01,381,690Mixed
State Street5,3380 02,205,987Withhold
Legg Mason00 01,423,151Withhold
Charles Schwab00 01,151,892Withhold
Manager Directed Portfolios850,9820 00For
MUTUAL FUND SERIES TRUST00 0718,814Withhold
Invesco444,2330 00For
Lord Abbett00 0428,862Withhold
Equitable00 0422,480Withhold
Jackson National00 338,3650Abstain
Columbia Threadneedle285,8260 00For
TIAA00 0267,839Withhold
Goldman Sachs00 0258,676Withhold
T. Rowe Price00 0255,946Withhold
QUANTITATIVE MASTER SERIES LLC00 237,9340Abstain
Voya229,7670 00For
First Trust00 0196,832Withhold
Northwestern Mutual46,1000 0128,081Mixed
DRIEHAUS MUTUAL FUNDS00 0162,578Withhold
Lincoln Financial00 0159,074Withhold
Hartford00 0150,709Withhold
Principal Exchange-Traded Funds00 0132,282Withhold
Principal00 0129,934Withhold

Showing the 25 largest of 85 asset managers. All 85 are in the interactive database (link above).

The vote to approve the amendment to the Company's 2022 Incentive Plan to increase the number of authorized shares of…

Calculated outcomeCOMPENSATIONPassed (calculated)

Combines 5 wordings of this item as funds reported it.

93% Majority: yes · of votes cast

FOR 93%
FOR: 82,034,592AGAINST: 5,788,439
Details: description as filed, official tally, votes by 94 asset managers

Description as filed by funds: To approve Amendment No. 2 to our 2022 Incentive Plan to increase the number of shares of common stock authorized for issuance under the 2022 Incentive Plan from 17,000,000 to 22,000,000 shares

TG THERAPEUTICS INC.’s own tally for this item (“4. The vote to approve the amendment to the Company's 2022 Incentive Plan to increase the number of authorized shares of Common Stock authorized for issuance under the 2022 Incentive Plan from 17,000,000 to 22,000,000”): 82,034,592 for, 5,788,439 against, per its Form 8-K filed June 13, 2025 (Item 5.07). FOR was more than half of the votes cast. Whether the item passed is for the filing to say; its statement has not been read for this item.

Outcome: Passed (calculated) — The company’s filing reports the vote counts but does not state the outcome; we calculated it from the counts: votes for exceeded votes against.
Support: 93% of votes cast — FOR ÷ (FOR + AGAINST); abstentions and broker non-votes are excluded.

The 94 asset managers below reported 40,684,108 for, 159,055 against, 2 withheld, 22,174 abstained.

FOR
FOR: 40,684,108AGAINST: 159,055ABSTAIN: 22,174WITHHOLD: 2
Largest asset managers voting on “To approve Amendment No. 2 to our 2022 Incentive Plan to increase the number of shares of common stock authori” at TG THERAPEUTICS INC., 2024-2025
Asset managerForAgainst AbstainWithheldVote
Vanguard16,252,54014 10For
BlackRock7,948,9740 00For
Fidelity3,895,1920 00For
State Street2,211,193132 00For
Legg Mason1,423,1510 00For
Charles Schwab1,151,8920 00For
Manager Directed Portfolios850,9820 00For
MUTUAL FUND SERIES TRUST718,8140 00For
Invesco444,2330 00For
Lord Abbett428,8620 00For
Equitable422,4800 00For
Jackson National338,3650 00For
Columbia Threadneedle285,8260 00For
TIAA267,8390 00For
Goldman Sachs258,6760 00For
T. Rowe Price255,9460 00For
QUANTITATIVE MASTER SERIES LLC237,9340 00For
Voya229,7670 00For
First Trust196,8320 00For
Northwestern Mutual174,1810 00For
DRIEHAUS MUTUAL FUNDS162,5780 00For
Lincoln Financial159,0740 00For
Hartford150,7090 00For
Principal Exchange-Traded Funds132,2820 00For
Principal129,9340 00For

Showing the 25 largest of 94 asset managers. All 94 are in the interactive database (link above).

Advisory vote to approve the compensation of the Company's named executive officers

Calculated outcomeFund totals may overlapCOMPENSATIONPassed (calculated)

Combines 7 wordings of this item as funds reported it.

54.5% Majority: yes · of votes cast

FOR 54.5%AGAINST
FOR: 47,864,737AGAINST: 39,988,402

Prior year: 57.7% for (June 14, 2024 meeting) ▼ 3.2 pts

Details: description as filed, official tally, votes by 343 asset managers

Description as filed by funds: An advisory vote to approve the compensation of our named executive officers.

TG THERAPEUTICS INC.’s own tally for this item (“3. The advisory vote to approve the compensation of the Company's named executive officers”): 47,864,737 for, 39,988,402 against, per its Form 8-K filed June 13, 2025 (Item 5.07). FOR was more than half of the votes cast. Whether the item passed is for the filing to say; its statement has not been read for this item.

Outcome: Passed (calculated) — The company’s filing reports the vote counts but does not state the outcome; we calculated it from the counts: votes for exceeded votes against.
Support: 54.5% of votes cast — FOR ÷ (FOR + AGAINST); abstentions and broker non-votes are excluded.

Fund voting reports and institutional-manager reports both cover this item. An institutional manager can report shares that a fund it advises also reports, so the two are shown separately below and never added together, and their sum is not shown (fund and manager reports combined may count the same shares twice).

Fund voting reports: 89 asset managers voting on “An advisory vote to approve the compensation of our named executive officers.” at TG THERAPEUTICS INC., 2024-2025
Asset managerForAgainst AbstainWithheldVote
Vanguard15,341,461911,093 10Mixed
BlackRock412,9537,536,021 00Mixed
Fidelity1,300,7592,594,433 00Mixed
State Street2,208,6312,694 00For
Legg Mason01,423,151 00Against
Charles Schwab01,151,892 00Against
Manager Directed Portfolios0850,982 00Against
MUTUAL FUND SERIES TRUST0718,814 00Against
Invesco0444,233 00Against
Lord Abbett0428,862 00Against
Equitable0422,480 00Against
Jackson National0338,365 00Against
Columbia Threadneedle0285,826 00Against
TIAA267,8390 00For
Goldman Sachs0258,676 00Against
T. Rowe Price0255,946 00Against
QUANTITATIVE MASTER SERIES LLC0237,934 00Against
Voya0229,767 00Against
First Trust0196,832 00Against
Northwestern Mutual0174,181 00Against
DRIEHAUS MUTUAL FUNDS0162,578 00Against
Lincoln Financial102,80056,274 00Mixed
Hartford0150,709 00Against
Principal Exchange-Traded Funds0132,282 00Against
Principal0129,934 00Against

Fund voting reports, all 89 managers: 19,855,917 for, 20,928,872 against, 2 withheld, 22,174 abstained. Showing the 25 largest; every one is in the interactive database (link above).

Institutional-manager reports: 276 asset managers voting on “An advisory vote to approve the compensation of our named executive officers.” at TG THERAPEUTICS INC., 2024-2025
Asset managerForAgainst AbstainWithheldVote
BlackRock510,8823,358,578 00Mixed
State Street3,762,60017,142 00For
GEODE CAPITAL MANAGEMENT, LLC02,791,787 00Against
Soleus Capital Management, L.P.2,574,4380 00For
Clearbridge Investments, LLC02,555,586 00Against
PICTET ASSET MANAGEMENT SA01,730,211 00Against
Hood River Capital Management LLC01,371,508 00Against
Fidelity1,304,3330 00For
Charles Schwab01,276,194 00Against
Northern Trust0937,817 00Against
Wellington0936,408 00Against
PRINCIPAL GLOBAL INVESTORS0846,021 00Against
Invesco0695,281 00Against
MELLON INVESTMENTS Corp0664,899 00Against
Opaleye Management Inc.535,0000 00For
BANK OF MONTREAL /CAN/0503,846 00Against
LORD, ABBETT & CO. LLC0497,746 00Against
Vanguard470,1758,945 00For
BRAUN STACEY ASSOCIATES INC0462,535 00Against
T. Rowe Price0412,981 00Against
PARAMETRIC PORTFOLIO ASSOCIATES LLC0369,921 00Against
DRIEHAUS CAPITAL MANAGEMENT LLC0339,656 00Against
Ensign Peak Advisors, Inc328,9920 00For
Voya0300,850 00Against
Nuveen280,1180 00For

Institutional-manager reports, all 276 managers: 10,391,354 for, 25,249,403 against, 34,528 abstained, 1,114 not voted. Showing the 25 largest; every one is in the interactive database (link above).

The ratification of KPMG LLP as the Company's independent registered public accounting firm for the fiscal year ending…

Calculated outcomeAUDIT-RELATEDPassed (calculated)

Combines 2 wordings of this item as funds reported it.

99.6% Majority: yes · of votes cast

FOR 99.6%
FOR: 117,836,086AGAINST: 442,199

Prior year: 99.4% for (June 14, 2024 meeting) ▲ 0.2 pts

Details: description as filed, official tally, votes by 90 asset managers

Description as filed by funds: To ratify the appointment of KPMG LLP as our independent registered public accounting firm for the year ending December 31, 2025.

TG THERAPEUTICS INC.’s own tally for this item (“2. The ratification of KPMG LLP as the Company's independent registered public accounting firm for the fiscal year ending December 31, 2025”): 117,836,086 for, 442,199 against, per its Form 8-K filed June 13, 2025 (Item 5.07). FOR was more than half of the votes cast. Whether the item passed is for the filing to say; its statement has not been read for this item.

Outcome: Passed (calculated) — The company’s filing reports the vote counts but does not state the outcome; we calculated it from the counts: votes for exceeded votes against.
Support: 99.6% of votes cast — FOR ÷ (FOR + AGAINST); abstentions and broker non-votes are excluded.

Also reported under other wordings, matched to the same row of TG THERAPEUTICS INC.’s official tally and shown with their own fund figures; their managers are not in the figures or the table on this card: “Ratify Appointment of Independent Auditors” (2 managers, 32,750 for).

The 90 asset managers below reported 40,648,962 for, 105,144 against, 22,173 abstained.

FOR
FOR: 40,648,962AGAINST: 105,144ABSTAIN: 22,173
Largest asset managers voting on “To ratify the appointment of KPMG LLP as our independent registered public accounting firm for the year ending” at TG THERAPEUTICS INC., 2024-2025
Asset managerForAgainst AbstainWithheldVote
Vanguard16,252,5541 00For
BlackRock7,948,9740 00For
Fidelity3,895,1920 00For
State Street2,211,3250 00For
Legg Mason1,423,1510 00For
Charles Schwab1,151,8920 00For
Manager Directed Portfolios850,9820 00For
MUTUAL FUND SERIES TRUST718,8140 00For
Invesco444,2330 00For
Lord Abbett428,8620 00For
Equitable422,4800 00For
Jackson National338,3650 00For
Columbia Threadneedle285,8260 00For
TIAA267,8390 00For
Goldman Sachs258,6760 00For
T. Rowe Price255,9460 00For
QUANTITATIVE MASTER SERIES LLC237,9340 00For
Voya229,7670 00For
First Trust196,8320 00For
Northwestern Mutual174,1810 00For
DRIEHAUS MUTUAL FUNDS162,5780 00For
Lincoln Financial159,0740 00For
Hartford150,7090 00For
Principal Exchange-Traded Funds132,2820 00For
Principal129,9340 00For

Showing the 25 largest of 90 asset managers. All 90 are in the interactive database (link above).

Largest TG THERAPEUTICS INC. shareholders voting in 2024-2025

Ranked separately for each type of Form N-PX report. An institutional manager can report shares that a fund it advises also reports, so the two tables can list the same shares and are never added together. Each is ranked by the shares voted on the item that the most managers of that type reported, shown as a share of the 158,168,688 shares outstanding at the time of that meeting.

Fund voting reports: top TG THERAPEUTICS INC. shareholders by shares voted on “An advisory vote to approve the compensation of our named executive officers.”, 2024-2025
#Asset manager % of shares outstanding
1Vanguard 10.28%
2BlackRock 5.03%
3Fidelity 2.46%
4State Street 1.40%
5Legg Mason 0.90%
6Charles Schwab 0.73%
7Manager Directed Portfolios 0.54%
8MUTUAL FUND SERIES TRUST 0.45%
9Invesco 0.28%
10Lord Abbett 0.27%
Institutional-manager reports: top TG THERAPEUTICS INC. shareholders by shares voted on “An advisory vote to approve the compensation of our named executive officers.”, 2024-2025
#Asset manager % of shares outstanding
1BlackRock 2.45%
2State Street 2.39%
3GEODE CAPITAL MANAGEMENT, LLC 1.77%
4Soleus Capital Management, L.P. 1.63%
5Clearbridge Investments, LLC 1.62%
6PICTET ASSET MANAGEMENT SA 1.09%
7Hood River Capital Management LLC 0.87%
8Fidelity 0.82%
9Charles Schwab 0.81%
10Northern Trust 0.59%

Reported TG THERAPEUTICS INC. holdings and ownership

As disclosed to the SEC in Form 13F (quarter-end holdings of 30 large managers), Schedules 13D and 13G (beneficial ownership above 5%) and the company’s own proxy statement (DEF 14A). Each row gives its source and the date its figure is as of: for Form 13F the quarter end it reports, for Schedules 13D and 13G the filing date, and for the proxy statement the date of its ownership table (or, where that date has not been read, the date the proxy was filed). The rows are therefore not all as of the same day.

TG THERAPEUTICS INC. holdings and ownership disclosed for the 2024-2025 proxy season, with each row’s source and date
HolderShares % outstandingSource, as of
BlackRock21,494,972 13.59%Form 13F, quarter ended March 31, 2025
Vanguard Group15,604,512 9.87%Form 13F, quarter ended March 31, 2025
State Street7,433,899 4.70%Form 13F, quarter ended March 31, 2025
Geode Capital3,282,567 2.08%Form 13F, quarter ended March 31, 2025
Morgan Stanley2,050,548 1.30%Form 13F, quarter ended March 31, 2025
Goldman Sachs1,919,416 1.21%Form 13F, quarter ended March 31, 2025
Nuveen1,798,989 1.14%Form 13F, quarter ended March 31, 2025
FMR (Fidelity)1,743,354 1.10%Form 13F, quarter ended March 31, 2025
Citadel Advisors1,603,277 1.01%Form 13F, quarter ended March 31, 2025
Northern Trust1,529,407 0.97%Form 13F, quarter ended March 31, 2025

Percentages above are of 158,168,688 shares outstanding, as reported by TG THERAPEUTICS INC. on its Form 10-Q dated March 31, 2025 (see the filing on EDGAR). This is the count contemporaneous with the 2024-2025 meeting, not today’s. Each holding is as of its own filing, which may be dated before or after the meeting.

About this meeting

At TG THERAPEUTICS INC.'s shareholder meeting held June 12, 2025, in the 2024-2025 proxy season, 343 asset managers reported votes on at least one of its 9 ballot items in their SEC Form N-PX filings, covering 3,068 separate fund positions. On the most widely held item on that ballot — An advisory vote to approve the compensation of our named executive officers. — FOR was 54.5% of the votes cast (FOR divided by FOR plus AGAINST, the conventional basis for proxy support; abstentions, broker non-votes and unvoted shares are excluded because none of them took a side), which is more than half. Whether the item was approved is for the filing to say; that statement has not been read for this item. Source: TG THERAPEUTICS INC.'s Form 8-K, Item 5.07, filed with the U.S. Securities and Exchange Commission on June 13, 2025.

Related

About this page

Every figure above is derived from filings made with the US Securities and Exchange Commission: Form N-PX, in which registered funds disclose how they voted every proxy and institutional managers disclose their votes on executive pay (say-on-pay, say-on-frequency and golden parachutes), and Form 8-K Item 5.07, in which the company reports its own meeting results. Shares outstanding are taken from TG THERAPEUTICS INC.’s 10-Q dated March 31, 2025. This page is a static snapshot rebuilt weekly on November 20, 2026; a live search always shows the current data.

TG THERAPEUTICS INC. proxy season coverage: 2023-2024 · 2024-2025 (this page) · 2025-2026.

Cite this page

Proxy Votes Now, “TG THERAPEUTICS (TGTX) 2025 Annual Meeting: Shareholder Vote Results”, https://proxyvotesnow.com/company/tg-therapeutics-inc/2025 (version of November 20, 2026). Derived from SEC Form N-PX and Form 8-K filings; tables licensed CC BY 4.0. Licence: CC BY 4.0.